Keros Therapeutics
KROS
KROS
107 hedge funds and large institutions have $731M invested in Keros Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 20 closing their positions.
Holders
107
Holders Change
-16
Holders Change %
-13.01%
% of All Funds
1.71%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
4
Increased
48
Reduced
29
Closed
20
Calls
$1.67M
Puts
$3K
Net Calls
+$1.67M
Net Calls Change
+$1.17M
Top Buyers
| 1 |
WP
1
Woodline Partners
San Francisco,
California
|
$22.9M |
| 2 |
2
Morgan Stanley
New York
|
$14.3M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$44.8M |
| 4 |
B
4
Braidwell
Stamford,
Connecticut
|
$43.3M |
| 5 |
5
Millennium Management
New York
|
$6.51M |
